NLRP3 and hepatocellular carcinoma: The loss of NLRP3 could inhibit MHC class I polypeptide‐related sequence A (MICA) exfoliation of HCC cells and increase the probability of natural killer group 2, member D–MICA interaction, thereby increasing the sensitivity of HCC to natural killer cell killing.21